BioCentury
ARTICLE | Company News

Juvenescence, partners form anti-aging biotech

August 14, 2018 2:02 PM UTC

Juvenescence Ltd. (Douglas, Isle of Man), Insilico Medicine Inc. (Baltimore, Md.) and the Buck Institute for Research on Aging (Novato, Calif.) partnered to form anti-aging company Napa Therapeutics Ltd. (Tortola, British Virgin Islands).

Napa will use Insilico's deep learning platform to discover small molecules against an undisclosed aging-related target in collaboration with Buck Institute President and CEO Eric Verdin's lab...